Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
One-Dose vs Two-Dose Penicillin Allergy Delabeling
NCT06303128Phase 3Recruiting
- Start
- Feb 2024
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amoxicillin in penicillin allergy. Started Feb 2024; status: recruiting.
02
Drugs
amoxicillin
03
Conditions
penicillin allergy
Beyond the preview
Go deeper on NCT06303128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06303128.